ARCHIVES

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

DCPC Board Kills Cost Sharing for CIS, Rejects Primary Care Prevention Effort Evaluation Budget

May 13, 1988

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009

AHCPR Funds Centers to Review Practice

July 4, 1997

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994